Liposomal Bupivacaine in Benign Soft Tissue Tumor Resection

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
Liposomal bupivacaine (Exparel) has been used as an adjunct to pain management in the perioperative setting. However, the efficacy of the drug has not bewen studied in patients with benign soft tissue tumor resections. The goal of the study is to see if Exparel controls pain and improves functional outcomes for patients after these procedures compared to the current standard Bupivacaine HCL.
Epistemonikos ID: fcd328630bbd4133e7439efd737c6cfe068b97fb
First added on: May 09, 2024